pravastatin has been researched along with Aseptic Necrosis of Femur Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Jiang, Y; Li, P; Lin, N; Lu, C; Xu, Y; Zhang, H; Zhang, Y; Zhu, B | 1 |
| Kumagai, K; Miyata, N; Niwa, M; Nozaki, Y | 1 |
2 other study(ies) available for pravastatin and Aseptic Necrosis of Femur Head
| Article | Year |
|---|---|
Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARĪ³ expression and activating Wnt signaling pathway.
Topics: Adipogenesis; Adipose Tissue; Adrenal Cortex Hormones; Animals; beta Catenin; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Femur Head; Femur Head Necrosis; Fibrinolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Low Density Lipoprotein Receptor-Related Protein-5; Male; Methylprednisolone; Neovascularization, Physiologic; Osteogenesis; Osteonecrosis; PPAR gamma; Pravastatin; Rats; Rats, Wistar; Wnt Signaling Pathway; Wnt3A Protein | 2014 |
Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.
Topics: Adipocytes; Animals; Anti-Inflammatory Agents; Bone Marrow; Disease Models, Animal; Drinking Water; Femur Head Necrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipid Metabolism; Male; Methylprednisolone; Methylprednisolone Acetate; Oxidative Stress; Pravastatin; Rats; Rats, Inbred SHR | 2012 |